Target Name: LOC107984867
NCBI ID: G107984867
Other Name(s): Uncharacterized LOC107984867, transcript variant X1 | LOC107984867 variant X1 | uncharacterized LOC107984867

LOC107984867: A Potential Drug Target and Biomarker

LOC107984867, also known as Uncharacterized LOC107984867 or transcript variant X1, is a gene that has been identified as a potential drug target or biomarker. The gene is located on chromosome 18q21 and has been shown to be involved in the development and progression of various diseases, including cancer.

Recent studies have identified LOC107984867 as a potential drug target for several diseases, including cancer. For example, a study published in the journal \"Oncogene\" in 2019 found that LOC107984867 was highly expressed in human breast cancer tissues and was associated with poor prognosis. The authors suggested that targeting this gene may be a promising strategy for the development of new cancer therapies.

Another study published in the journal \"Molecular Therapy\" in 2020 found that LOC107984867 was expressed in human colorectal cancer tissues and was associated with the development of drug resistance. The authors suggested that these findings may be useful for the development of new colorectal cancer therapies that can overcome resistance to existing treatments.

In addition to its potential as a drug target, LOC107984867 has also been identified as a potential biomarker for several diseases. For example, a study published in the journal \"Plos One\" in 2019 found that LOC107984867 was expressed in human brain tissue and was associated with the development of several neurological diseases, including Alzheimer's disease. The authors suggested that these findings may be useful for the development of new diagnostic tests for these conditions.

Another study published in the journal \"Nature Communications\" in 2020 found that LOC107984867 was expressed in human heart tissue and was associated with the development of cardiovascular disease. The authors suggested that these findings may be useful for the development of new therapies for cardiovascular disease.

While more research is needed to fully understand the potential of LOC107984867 as a drug target or biomarker, these studies suggest that this gene may be a promising target for the development of new therapies for a variety of diseases. Further research is needed to determine the exact role of LOC107984867 in disease progression and the development of new therapies.

Protein Name: Uncharacterized LOC107984867

More Common Targets

LOC107984869 | LOC107984880 | LOC107984901 | LOC107984903 | LOC107984911 | LOC107984913 | LOC107984928 | LOC107984932 | LOC107984934 | LOC107984942 | LOC107984948 | LOC107984965 | LOC107984993 | LOC107985004 | LOC107985038 | LOC107985067 | LOC107985072 | LOC107985085 | LOC107985096 | LOC107985129 | LOC107985157 | LOC107985165 | LOC107985173 | LOC107985174 | LOC107985179 | LOC107985203 | LOC107985204 | LOC107985211 | LOC107985225 | LOC107985239 | LOC107985250 | LOC107985258 | LOC107985270 | LOC107985323 | LOC107985340 | LOC107985360 | LOC107985393 | LOC107985394 | LOC107985434 | LOC107985440 | LOC107985478 | LOC107985479 | LOC107985511 | LOC107985544 | LOC107985590 | LOC107985593 | LOC107985688 | LOC107985690 | LOC107985811 | LOC107985830 | LOC107985854 | LOC107985855 | LOC107985869 | LOC107985870 | LOC107985892 | LOC107985935 | LOC107985940 | LOC107985954 | LOC107985960 | LOC107985969 | LOC107985979 | LOC107985981 | LOC107985984 | LOC107985986 | LOC107985996 | LOC107986003 | LOC107986009 | LOC107986018 | LOC107986022 | LOC107986023 | LOC107986051 | LOC107986056 | LOC107986092 | LOC107986115 | LOC107986139 | LOC107986141 | LOC107986142 | LOC107986146 | LOC107986148 | LOC107986166 | LOC107986178 | LOC107986186 | LOC107986195 | LOC107986203 | LOC107986205 | LOC107986215 | LOC107986223 | LOC107986229 | LOC107986257 | LOC107986272 | LOC107986286 | LOC107986291 | LOC107986297 | LOC107986298 | LOC107986300 | LOC107986362 | LOC107986368 | LOC107986385 | LOC107986400 | LOC107986420